Nano-X Imaging ( (NNOX) ) has shared an announcement.
On February 25, 2025, Nano-X Imaging Ltd announced it received CE mark certification for its Nanox.ARC system, allowing it to market the system in Europe. This milestone follows the recent FDA clearance in the U.S., positioning Nanox for expanded commercial deployment. The Nanox.ARC system, featuring advanced tomosynthesis technology, provides enhanced imaging capabilities with reduced radiation exposure, bridging the gap between traditional X-rays and CT scans. This certification is expected to accelerate Nanox’s commercial introduction across Europe, potentially broadening its global market presence and offering significant value to medical practices and patients.
More about Nano-X Imaging
Nanox Imaging Ltd, listed on NASDAQ as NNOX, is a pioneering company in the medical imaging technology sector. The company focuses on transitioning the world towards preventive healthcare by offering affordable medical imaging technologies. Its flagship products include the Nanox.ARC, a multi-source digital tomosynthesis system, and the Nanox.CLOUD, a cloud-based platform for managing imaging data. Nanox aims to enhance early detection and treatment through its advanced AI-driven solutions.
YTD Price Performance: -32.13%
Average Trading Volume: 3,784,786
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $352.2M
For a thorough assessment of NNOX stock, go to TipRanks’ Stock Analysis page.